Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Efforts to Improve Quality of Migraine Care
    Release Date:
    Partner: The Japanese Headache Society
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Internal Medicine Japan
    Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease USA
    2026 Hemophilia Fellowship – United States
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Rare Disease All
    Improving Precision Oncology Care Through Molecular Diagnostic Integration and Data Quality Improvement
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology Kazakhstan
    Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer Care
    Release Date:
    Partner: Prostate Cancer Foundation
    Review Process: Expert Review Panel
    Education Oncology USA
    Improving Shared Decision Making in Hemophilia: Visiting Professorship Program
    Release Date:
    Partner: Hemostasis & Thrombosis Research Society (HTRS)
    Review Process: Expert Review Panel
    Education Rare Disease USA
    Improving Metastatic Prostate Cancer (mPCa) Care Through Innovative Strategies
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Oncology All
    Novel Therapies for Relapsed/Refractory Large B-Cell Lymphoma in Community Oncology Practice
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology China, France, Germany, Italy, Japan, Spain, Turkey, United Kingdom
    Pre-clinical Investigation of anti-TFPI-mediated Rebalancing Mechanisms in Non-Hemophilic Bleeding Disorders
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Enzalutamide in the Treatment of Prostate Cancer
    Release Date:
    Partner: National Comprehensive Cancer Network, Astellas
    Review Process: Expert Review Panel
    Research Oncology USA
    Education of Healthcare Professionals to Provide Appropriate Medical Care for Patients with Atopic Dermatitis
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Japan
    Addressing Primary Immunodeficiencies within Minority/Underserved Populations
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Nurse Navigator Competitive Grant Program
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease USA
    Patient and Caregiver Awareness of Drug Resistant Infections (United States and Europe)
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research – U.S.
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease USA
    Establishment of Hospital-Clinic Collaboration Model for Undiagnosed Rheumatic Diseases
    Release Date:
    Partner: The Japan College of Rheumatology
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology Japan
    Establishment of Support System for Healthy Life Extension of Patients with CV disease
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine Japan
    A Quality Improvement Grant Request for Proposals Addressing Social Health Needs in Chronic and Preventative Disease
    Release Date:
    Partner: IHI
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine USA
    Racial and Ethnic Disparities in the Menopause Experience
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    Immunotherapy in Urothelial Carcinoma
    Release Date:
    Partner: Merck KGaA Darmstadt, Germany and EMD Serono
    Review Process: Pfizer Internal
    Education Oncology All
    Managment of Metabolic Risks that Drive Liver Diseases and Increase Cardiovascular Risk in NASH
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine All